Immungene Inc.
Records under this name other than the patents Immungene Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 4 of 4 · Back to Immungene Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,534,057 | Methods of treating tumors with engineered antibody-interferon mutant fusion molecules Lapsed on the fee record Ended Jan 3, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jan 3, 2025 | From the USPTO record |
| US 10,259,854 | Engineered antibody-interferon mutant fusion molecules Lapsed on the fee record Ended Apr 16, 2023 · From the USPTO record | Lapsed on the fee record | Ended Apr 16, 2023 | From the USPTO record |
| US 9,783,589 | Engineered antibody-interferon fusion molecules for treatment of autoimmune diseases Lapsed on the fee record Ended Oct 10, 2021 · From the USPTO record | Lapsed on the fee record | Ended Oct 10, 2021 | From the USPTO record |
| US 9,534,056 | Engineered TAA antibody-TNFSF member ligand fusion molecules Lapsed on the fee record Ended Jan 3, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jan 3, 2021 | From the USPTO record |